Telix Pharmaceuticals now on the buy list at Jarden Brokers
SYDNEY: Shares in cancer biotech Telix Pharmaceuticals are up 51.5 per cent for ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
